COVID-19 IgM IgG Rapid Test Kits Market

Serology testing for COVID-19 is at increased demand in order to better quantify the number of cases of COVID-19, including those that may be asymptomatic or have recovered. Serology tests are blood-based tests that can be used to identify whether people have been exposed to a particular pathogen by looking at their immune response.

COVID-19 IgM IgG Rapid Test Kits Market contains market size and forecasts of COVID-19 IgM & IgG Rapid Test Kits in global, including the following market information:

Global COVID-19 IgM & IgG Rapid Test Kits Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global COVID-19 IgM & IgG Rapid Test Kits Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five COVID-19 IgM & IgG Rapid Test Kits companies in 2021 (%)

The global COVID-19 IgM & IgG Rapid Test Kits market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

RDT(Rapid Diagnostic Test) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of COVID-19 IgM & IgG Rapid Test Kits include Cellex, RayBiotech, Biopanda, BioMedomics, GenBody, SD Biosensor, Advaite, Premier Biotech and Epitope Diagnostics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the COVID-19 IgM & IgG Rapid Test Kits manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global COVID-19 IgM & IgG Rapid Test Kits Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global COVID-19 IgM & IgG Rapid Test Kits Market Segment Percentages, by Type, 2021 (%)

• RDT(Rapid Diagnostic Test)
• ELISA(Enzyme-linked Immunosorbent Aassay)
• Neutralization Assay

Global COVID-19 IgM & IgG Rapid Test Kits Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global COVID-19 IgM & IgG Rapid Test Kits Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Special Clinic
• Research Institutions

Global COVID-19 IgM & IgG Rapid Test Kits Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global COVID-19 IgM & IgG Rapid Test Kits Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies COVID-19 IgM & IgG Rapid Test Kits revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies COVID-19 IgM & IgG Rapid Test Kits revenues share in global market, 2021 (%)
• Key companies COVID-19 IgM & IgG Rapid Test Kits sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies COVID-19 IgM & IgG Rapid Test Kits sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Cellex
• RayBiotech
• Biopanda
• BioMedomics
• GenBody
• SD Biosensor
• Advaite
• Premier Biotech
• Epitope Diagnostics
• CTK Biotech
• Creative Diagnostics
• Eagle Biosciences
• Sure Biotech
• Sugentech
• Sensing self
• Euroimmun AG
• PharmACT
• Liming Bio
• Beijing Wantai
• Livzon Diagnostics
• Shenzhen BioEasy Biotechnology
• Orient Gene Biotech
• INNOVITA
• Dynamiker
• Guangzhou Wonfo Bio-Tech